63
Publications
3.5K
Citations
30
H-Index
1994
Active since
Michael Steurer is an author at Innsbruck Medical University specializing in medicine, oncology, and immunology.
Top concepts
MedicineOncologyHematologyCancer ResearchPathologyImmunologyCell BiologyHealthTumor BiologyPharmacotherapy
Publications per year
1994–2021
63
63
Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients
Carlo Gambacorti‐Passerini, Francesca Farina, Alessandra Stasia et al. · JNCI Journal of the National Cancer Institute · 2014 · 275 citations
Hematological Malignancy, Lymphoid Neoplasia, Alk+ Lymphoma Patients +9
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib
Johann Kern, Gerold Untergasser, Christoph Zenzmaier et al. · Blood · 2009 · 128 citations · Full text
BRAF inhibition in hairy cell leukemia with low-dose vemurafenib
Sascha Dietrich, Andreas Pircher, Volker Endris et al. · Blood · 2016 · 128 citations · Full text
Rows per page
1–5 of 63